GWAS 2021-10-06

Quintanilha JCF, Wang J et al.

Br J Cancer

Hypertension and proteinuria are common bevacizumab-induced toxicities. No validated biomarkers are ...

Bevacizumab-induced hypertension

1039

Participants

N/A

Studies

GWAS 2014-08-12

Schneider BP, Li L et al.

Br J Cancer

Bevacizumab has broad anti-tumour activity, but substantial risk of hypertension. No reliable marker...

Response to chemotherapy in breast cancer (hypertension) (bevacizumab)

642

Participants

N/A

Studies

Title

Author

Journal

Disease/Trait

Date

Actions

Quintanilha JCF, Wang J et al.

Br J Cancer

Bevacizumab-induced hypertension

2021-10-06

Schneider BP, Li L et al.

Br J Cancer

Response to chemotherapy in breast cancer (hypertension) (bevacizumab)

2014-08-12